Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • BioTech • AgroTech • Businesses Solutions • Energy • Entertainment (& Sports) • IoT (& Wearables) • CleanTech • HealthTech (& Fitness) • Food & Beverage • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Consumer • Woman Focused |
Stages | Early,Seed,Later, Series A, Series B, Pre-seed |
Investing | United States • Europe |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
iSelect Fund is a venture capital firm specializing in investments across multiple sectors including Software, Biotech, AgroTech, Entertainment & Sports, IoT & Wearables, CleanTech, HealthTech & Fitness, Food & Beverage, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, and Woman Focused industries. With a focus on early to later stage companies, iSelect Fund targets investments in the Southeast, Midwest, Great Lakes, and Mountain regions of the United States. Their investment thesis revolves around the convergence of AgTech and human health, emphasizing soil health, early detection, intervention, and prevention of chronic or metabolic diseases. The firm aligns with the philosophy that better food choices lead to better health outcomes and that technological innovation is crucial for improving farm operations, healthcare delivery, and treatment strategies. As an impact and performance-driven fund, iSelect Fund is also committed to addressing the challenges in food and healthcare sectors through venture capital funding. The company operates uniquely, allowing investors to individually assess and opt into deals, rather than pooling capital upfront. iSelect Fund looks to fund scalable companies that can yield significant returns through solutions that create positive societal impacts, specifically in agricultural production and healthy food provision. Minimum investments start at $100,000, with a preferred investment 'sweet spot' of around $1,500,000, and a maximum investment ceiling of $5,000,000. The firm is interested in a wide array of specialities ranging from Pre-seed to Series B stages. However, they do not show interest in consumer brands, small molecule therapeutics, or solutions unrelated to chronic or metabolic disease. Through a robust network of investors, entrepreneurs, and industry experts, the fund endeavors to accelerate innovation and drive transformations that enhance health and longevity.